THIENO(2,3-C)PYRROL-4-ONE DERIVATIVES AS ERK INHIBITORS

The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors JOSEPH Sajan, CORTEZ Guillermo S, MCMILLEN William T, MCLEAN Johnathan Alexander, ZHAO Gaiying, RODRIGUEZ Michael John
Format Patent
LanguageEnglish
Slovenian
Published 30.08.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.
Bibliography:Application Number: SI20150030773T